BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18629498)

  • 1. Long-term management of thrombocytosis in essential thrombocythaemia.
    Birgegård G
    Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options for essential thrombocythemia and polycythemia vera.
    Solberg LA
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anagrelide: a review of its use in the management of essential thrombocythaemia.
    Wagstaff AJ; Keating GM
    Drugs; 2006; 66(1):111-31. PubMed ID: 16398570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential thrombocythaemia in children: is a treatment needed?
    Randi ML; Putti MC
    Expert Opin Pharmacother; 2004 May; 5(5):1009-14. PubMed ID: 15155103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on diagnosis and management of essential thrombocythemia.
    Gisslinger H
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):430-6. PubMed ID: 16810619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
    Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary thrombocythemia: diagnosis and therapy].
    Petrides PE
    Med Klin (Munich); 2006 Aug; 101(8):624-34. PubMed ID: 16896569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytosis.
    Schafer AI
    N Engl J Med; 2004 Mar; 350(12):1211-9. PubMed ID: 15028825
    [No Abstract]   [Full Text] [Related]  

  • 11. Anagrelide: what was new in 2004 and 2005?
    Petrides PE
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):399-408. PubMed ID: 16810615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythaemia vera and essential thrombocythaemia: current treatment strategies.
    Penninga EI; Bjerrum OW
    Drugs; 2006; 66(17):2173-87. PubMed ID: 17137402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential thrombocythemia.
    Brière JB
    Orphanet J Rare Dis; 2007 Jan; 2():3. PubMed ID: 17210076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How would I manage a case of essential thrombocythaemia presenting with an ischaemic toe.
    McLornan D; McMullin M
    Hematol Oncol; 2008 Mar; 26(1):3-7. PubMed ID: 17968848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical spectrum of thrombocytosis and thrombocythemia.
    Frenkel EP
    Am J Med Sci; 1991 Jan; 301(1):69-80. PubMed ID: 1994734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary management of essential thrombocythemia in children.
    Randi ML; Bertozzi I; Putti MC
    Expert Rev Hematol; 2019 May; 12(5):367-373. PubMed ID: 30925843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of essential thrombocythaemia: economic considerations.
    Griesshammer M; Langer C
    Expert Opin Pharmacother; 2003 Sep; 4(9):1499-505. PubMed ID: 12943479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment practice for essential thrombocythaemia in adults.
    Griesshammer M; Bangerter M; Grünewald M
    Expert Opin Pharmacother; 2001 Mar; 2(3):385-93. PubMed ID: 11336593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia.
    Finazzi G; Barbui T
    Leukemia; 2008 Aug; 22(8):1494-502. PubMed ID: 18596737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness considerations in the treatment of essential thrombocythemia.
    Golub R; Adams J; Dave S; Bennett CL
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):28-32. PubMed ID: 12096355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.